Construction of rAAV2-GPIIb/IIIa vector and test of its expression and function in vitro.
- Author:
Kai WANG
1
;
Jian-Qiang PENG
;
Fang-Ping CHEN
;
Xiao-Bin WU
Author Information
1. Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China.
- Publication Type:Journal Article
- MeSH:
Dependovirus;
genetics;
metabolism;
Genetic Vectors;
genetics;
Humans;
Platelet Glycoprotein GPIIb-IIIa Complex;
biosynthesis;
genetics;
Platelet Membrane Glycoprotein IIb;
genetics;
metabolism;
RNA, Messenger;
biosynthesis;
genetics;
Recombinant Fusion Proteins;
biosynthesis;
genetics;
Thrombasthenia;
metabolism;
therapy
- From:
Journal of Experimental Hematology
2006;14(2):369-374
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to explore the possibility of rAAV2 vector-mediating gene therapy for Glanzmann' s thrombasthenia. The rAAV2-GPIIb/IIIa vector was constructed. The GPIIb/IIIa gene expression in mammal cell were examined by different methods, such as: detection of mRNA expression in BHK-21 cells after 24 hours of infection (MOI = 1 x 10(5) v.g/cell) was performed by RT-PCR; the relation between MOI and quantity of GPII6/IIIa gene expression was detected by FACS after 48 hours of infection; GPIIb/IIIa protein expression in BHK-21 cells after 48 hours of infection (MOI = 10(5) v x g/cell) was assayed by Western blot, GPIIb/IIIa protein expression on cell surface was detected by immunofluorescence, and the biological function of expressing product was determined by PAC-1 conjunct experiments. The results showed that GPIIb/IIIa gene expression in mRNA level could be detected in BHK-21 cells after 24 hours of infection at MOI = 1 x 10(5) v x g/cell and the GPIIb/IIIa gene expression in protein level could be detected in BHK-21 cells after 48 hours of infection at MOI = 1 x 10(5) v x g/cell. In certain range, quantity of GPIIb/IIIa gene expression increased with MOI, but overdose of MOI decreased quantity of GPIIb/IIIa gene expression. Activated product of GPIIb/IIIa gene expression could combined with PAC-I, and possesed normal biological function. In conclusion, rAAV2 vactor can effectively mediate GPIIb and GPIIIa gene expressing in mammal cells, and the products of these genes exhibit biological function. This result may provide a basis for application of rAAV2 vector in Glanzmann's thrombasthenia gene therapy in furture.
